Search company, investor...
Stockpile company logo


Founded Year



Series B | Alive

Total Raised


Last Raised

$30M | 5 yrs ago

About Stockpile

Stockpile aims to make it easy for millennials and beginners of any age, including children, to learn about stock, get started investing in stocks or to gift stocks. Stockpile enables customers to buy fractional shares with as little as $5 making it possible for anyone to own stock in their favorite companies, including Amazon, Apple, Alphabet, Disney, Nike, Tesla and 1,000 other popular stocks as well as ETFs.

Headquarters Location

500 N Brand Blvd Suite 1760

Glendale, California, 91203,

United States


Missing: Stockpile's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Stockpile's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Stockpile

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Stockpile in 2 CB Insights research briefs, most recently on Apr 14, 2022.

Expert Collections containing Stockpile

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Stockpile is included in 2 Expert Collections, including Wealth Tech.


Wealth Tech

1,920 items

A category of financial technology that is digitizing & streamlining the delivery of wealth management. Included: Startups that offer technology-enabled tools for active and passive wealth management for retail investors and advisors.



7,750 items

US-based companies

Stockpile Patents

Stockpile has filed 5 patents.

The 3 most popular patent topics include:

  • Derivatives (finance)
  • Financial markets
  • Options (finance)
patents chart

Application Date

Grant Date


Related Topics



Financial markets, Derivatives (finance), Payment systems, Options (finance), Securities (finance)


Application Date


Grant Date


Related Topics

Financial markets, Derivatives (finance), Payment systems, Options (finance), Securities (finance)



Latest Stockpile News

US Releasing Monkeypox Vaccine from National Stockpile

May 24, 2022

National Stockpile May 24, 2022 The U.S. has begun releasing a monkeypox vaccine from the Strategic National Stockpile to protect high-risk people. The two-dose vaccine is approved to prevent smallpox and monkeypox. "I can report that there has been a request for release of the Jynneos vaccine from the National Stockpile for some of the high-risk contacts of some of the early patients, so that is actively happening right now," Jennifer McQuiston, deputy director of the Division of High Consequence Pathogens and Pathology at the CDC's Emerging and Zoonotic Infectious Diseases Center, said during a news briefing . Approved in the U.S. in 2019, the Jynneos vaccine is meant for use in high-risk adults, according to Reuters . McQuiston said the U.S. has a "good stock" of doses because it has prepared for the possibility of needing the vaccine for smallpox. "Right now, we have over 1,000 doses of that available," McQuiston said. "We expect that level to ramp up very quickly in the coming weeks as the company provides more doses to us." ACAM2000 is another smallpox vaccine licensed in the U.S. It could be used to prevent monkeypox as well, and the U.S. has more than 100 million doses. "ACAM2000 is an older-generation smallpox vaccine that has some potential significant side effects with it," McQuiston said. "So, a decision to use that widely would have to have some serious discussion behind it." First, federal health officials plan to use a few vaccines among close contacts of the current patients to prevent the virus from spreading, according to CNN . "We are hoping to maximize vaccine distribution to those that we know would benefit from it," McQuiston said. "Those are people who've had contact with known monkeypox patients, health care workers — very close personal contact — and those in particular who might be at high risk for severe disease." By the CDC's count, the first confirmed monkeypox case in the U.S. is a man from Massachusetts who recently traveled to Canada. At least six suspected cases span across the country, according to ABC News , with one in New York, two in Florida, two in Utah and one in Washington. They tested positive for orthopoxvirus, the family of viruses that includes monkeypox. As of Tuesday afternoon, there was also one suspected case of monkeypox under investigation in Sacramento County, CA, local news station KTXL reported . The suspected case was identified in a person who had recently traveled to Europe. Given the current outbreak, health care providers should assume that orthopox cases are monkeypox, McQuiston said. The CDC expects to receive samples from the suspected cases and test them this week. "It is likely that there are going to be additional cases reported in the United States," she said. On Monday, Seattle health officials announced that a "presumptive" case is being investigated in an adult male who traveled internationally during the past month to a country that had reported monkeypox cases, according to The Associated Press . The initial testing was completed Monday at a state laboratory, the AP reported. Federal health officials will confirm the case. The man wasn't hospitalized and is isolating at home, Seattle health officials said, noting  that they don't believe there is a high risk to the public. Also on Monday, the CDC issued a travel alert to "practice enhanced precautions" as monkeypox spreads in multiple countries. Cases have now been confirmed in more than 16 countries. "Risk to the general public is low, but you should seek medical care immediately if you develop new, unexplained skin rash (lesions on any part of the body), with or without fever and chills," the CDC wrote. The World Health Organization  announced Tuesday that there have been 131 confirmed cases and 106 additional suspected cases outside of Africa since the first case was reported on May 7, according to Reuters . Although the multi-country outbreak is unusual, it remains "containable" and limited, WHO officials said. International health officials are meeting this week and next week to talk about how to tackle the situation. Sources: CNN: "US in process of releasing monkeypox vaccine from national stockpile for ‘high-risk' people, CDC says." CDC: "CDC Media Telebriefing: Update on 2022 U.S. Monkeypox Investigation," "Travel Notices: Monkeypox in Multiple Countries." Reuters: "U.S. health officials releasing some Jynneos vaccine doses for monkeypox — CDC," "WHO says monkeypox outbreak ‘containable,' confirms 131 cases outside Africa." ABC News: "1 confirmed, 6 presumptive monkeypox cases in US, government releasing vaccines for exposed." The Associated Press: "Presumptive case of monkeypox reported in Seattle area." Credit:

Stockpile Frequently Asked Questions (FAQ)

  • When was Stockpile founded?

    Stockpile was founded in 2010.

  • Where is Stockpile's headquarters?

    Stockpile's headquarters is located at 500 N Brand Blvd, Glendale.

  • What is Stockpile's latest funding round?

    Stockpile's latest funding round is Series B.

  • How much did Stockpile raise?

    Stockpile raised a total of $45M.

  • Who are the investors of Stockpile?

    Investors of Stockpile include Mayfield, Arbor Ventures, Hanna Ventures, Eight Roads Ventures, Wang Ventures and 4 more.

  • Who are Stockpile's competitors?

    Competitors of Stockpile include Bumped.

Compare Stockpile to Competitors

Stash Logo

Stash is a mobile app offering users a way to invest based on goals, interests, and beliefs. Stash helps people start investing with small sums, gain investing confidence gradually, and build smart financial habits for the long term. Stash was formerly known as Collective Returns. The company was founded in 2015 and is based in New York, New York.

Bits of Stock Logo
Bits of Stock

Bits of Stock operates a consumer reward platform. Its platform drives loyalty for brands, replacing traditional points, loyalty cards, and cashback programs with assets that grow in value over time. It is a direct-to-consumer firm. It was founded in 2017 and is based in New York, New York.

TiiCKER Logo

TiiCKER develops a community platform that provides publicly traded companies a way to measure and engage individual investors.


Upstreet, founded in 2019, offers shoppers fractional share rewards with every eligible purchase at a range of Australian and international brands. It is based in Sydney, New South Wales.

DriveWealth Logo

DriveWealth is a global brokerage infrastructure that offers investment capabilities and real-time fractional trading through partners. DriveWealth’s suite of embedded finance APIs enables global partners to access the U.S. securities market.

Alpaca Logo

Alpaca is a Silicon Valley-based API stock brokerage for developers and bots. Alpaca is dismantling the old system of stock trading that required investors to constantly monitor stocks and enter buy and sell orders manually by introducing a commission-free trading platform where individuals can easily use algorithms, trading bots and artificial intelligence.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.